Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters

Seymen P., Yildiz M. , Turkmen M. F. , Titiz M. I. , Seymen H. O.

TRANSPLANTATION PROCEEDINGS, cilt.41, ss.4181-4183, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 41 Konu: 10
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1016/j.transproceed.2009.09.069
  • Dergi Adı: TRANSPLANTATION PROCEEDINGS
  • Sayfa Sayıları: ss.4181-4183

Özet

Objective. In renal transplant recipients, cyclosporine treatment appears to cause more frequent hyperlipidemia than tacrolimus usage. In this study, hyperlipidemic renal transplant recipients who use cyclosporine were investigated for changes in high-density lipoprotein (HDL)-2/3, apolipoprotein (Apo) A1/B, other lipid and biochemical parameters, and body mass index after prospective cyclosporine to tacrolimus switching.